
Life sciences venture firm investing in early-stage treatments and diagnostics for rare diseases

Venture arm of a Moroccan university backing early-stage science and technology startups across Africa

UM6P Ventures is the investment arm of University Mohammed VI Polytechnic and works as a venture capital firm for young companies. It was created to advance entrepreneurship and bring scientific research to market in Morocco and across Africa. It runs two funds, one for digital transformation startups and one for deeptech ventures.
Innovators and early-stage founders with a skilled, complementary team and scale potential. It is sector agnostic and names deeptech, hardtech, rural and remote-site solutions, AI, agriculture, chemicals, green technology and health technology.
Summary written by TrustList from the business's own published information, Sep 2026.
2 images - click to enlarge
UM6P Ventures is ranked on 2 TrustList rankings: #19 on 1 and #23 on 1.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. UM6P Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is the only one of the 20 here listing agritech and one of 3 here listing science.
Of the 20 here, 4 also cover growth stage and 4 also cover healthtech; 6 also work in New York City and 3 also work in San Francisco.
Behind SIX FinTech Ventures, ahead of Vodia Ventures.
It is the only one of the 23 here listing corporate venture capital.
Of the 23 here, 6 also cover agriculture and 5 also cover partners; 4 also work in Paris and 3 also work in London.
Behind Tenacious Ventures.
As of 2026-10-31. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about UM6P Ventures.
Similar listings buyers compare against this one.

Life sciences venture firm investing in early-stage treatments and diagnostics for rare diseases

Life sciences venture fund backing biotech and biopharma companies from seed to later stage across three regions

Venture investor whose portfolio centres on advertising technology, media and online platforms

Strategic venture fund of Boehringer Ingelheim investing worldwide in pioneering science for patients

Public-private venture fund investing in research-based start-ups in Georgia

Seed stage venture capital firm backing US startups with financing, mentoring and marketing consulting
Everything here links back to the same verified catalogue. Pick your next stop.